Latest stories on WGS
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
StockTitan50 · neutralgeneral
GeneDx enhances genome testing portfolio with long-read whole-genome sequencing
The Fly58 · neutralproduct/pr
GeneDx announces plans to enhance genome testing portfolio with lrWGS
The Fly58 · neutralproduct/pr
GeneDx Expands Diagnostic Leadership with Long-Read Genome Sequencing, Advancing Rare Disease Diagnosis
StockTitan61 · neutralproduct/pr
GeneDx Advances Clinical Adoption of Genomic Medicine with 27 Abstracts at ASHG 2026
StockTitan58 · neutralproduct/pr
GeneDx presents new findings on genomic newborn screening at ICoNS 2026
The Fly56 · neutralproduct/pr
GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
StockTitan63 · neutralproduct/pr
GeneDx to introduce Easy Order at AAP 2026
The Fly56 · neutralproduct/pr
GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
StockTitan63 · neutralproduct/pr
GeneDx selloff after CMS news ‘probably too extreme,’ says Craig-Hallum
The Fly38 · neutralgeneral
GeneDx, Beren Therapeutics launch NPC GenomeComplete
The Fly63 · neutralproduct/pr
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
StockTitan63 · neutralproduct/pr
GeneDx CEO Katherine Stueland Recognized as a 2026 Fierce 50 Honoree
StockTitan63 · neutralgeneral
GeneDx announces data published in Genetics in Medicine on genome sequencing
The Fly63 · neutralproduct/pr
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
StockTitan73 · bullishproduct/pr
GeneDx: Why I Think The Worst Is Behind The Business
Seeking Alpha63 · neutralanalyst
Genedx Launches New Online Offering To Expand Accessibility Of Exome Testing
The Fly63 · neutralproduct/pr
GeneDx (WGS) Q2 2026 Earnings Call Transcript
The Motley Fool71 · bullishearnings
GeneDx to Participate in Upcoming Investor Conferences
StockTitan56 · neutralgeneral
GeneDx Holdings Corp. Earnings Call Highlights Risks
TipRanks46 · neutralearnings
Genedx reaffirms 2026 revenue guidance of $475M-$490M while expecting meaningful collection-rate uplift starting in Q4
Seeking Alpha63 · neutralearnings
GeneDx Holdings Corp. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
GeneDx Holdings Corp. (WGS) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
GeneDx Q2 Earnings Call Highlights
Yahoo Finance73 · bullishearnings